Beta Interferons News and Research

RSS
Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers develop fast diagnostic tool that shows MS patients in relapse

UBC researchers uncover potential adverse reactions of common multiple sclerosis drug

UBC researchers uncover potential adverse reactions of common multiple sclerosis drug

IQWiG study finds no added benefit of teriflunomide

IQWiG study finds no added benefit of teriflunomide

Elan, Biogen Idec submit applications to FDA and EMA for updation of TYSABRI labels

Elan, Biogen Idec submit applications to FDA and EMA for updation of TYSABRI labels

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

High cost of multiple sclerosis drugs

High cost of multiple sclerosis drugs

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists discover molecular mechanism that could help develop new MS treatments

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

Body uses a 'dual key' system to secure immune system

Body uses a 'dual key' system to secure immune system

Atorvastatin could prove an effective therapy for multiple sclerosis

Atorvastatin could prove an effective therapy for multiple sclerosis

No evidence that Glatiramer acetate slows multiple sclerosis progression

No evidence that Glatiramer acetate slows multiple sclerosis progression

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease